GLUE   $8.48  1.56% Market Closed After Close 8.49 0.12%

Monte Rosa Therapeutics Inc
Total Cash 262.20M
totalCashPerShare 4.273
EBITDA -131.78M
Total Debt 44.36M
quickRatio 6.424
currentRatio 6.562
Total Revenue 5.76M
debtToEquity 19.743
Revenue/Share 0.097
ROA -0.27986
ROE -0.59506
grossProfits
freeCashflow -57.04M
operatingCashflow -61.00M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -6.9525
profitMargins 0.0
enterpriseValue 362.07M
forwardPE -5.3089886
floatShares 38.14M
sharesOutstanding 61.37M
sharesShort 5.23M
sharesShortPriorMonth 3.27M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.84%
Short Ratio help_outline 8.36%
shortPercentOfFloat 0.16%
impliedSharesOutstanding
bookValue 3.664
Price To Book help_outline 2.58
earningsQuarterlyGrowth
netIncomeToCommon -130.41M
trailingEps -2.24%
forwardEps -1.78%
enterpriseToEbitda -2.75
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.49 3Q 2024
institutionsCount 116
lastUpdated Nov. 7, 2024, 5:09 a.m.